<DOC>
	<DOCNO>NCT01432509</DOCNO>
	<brief_summary>The purpose study identify prediabetic subject , physiopathological change involve evolution type 2 diabetes mellitus identify new biomarkers type 2 diabetes risk population .</brief_summary>
	<brief_title>Prospective Follow-up Cohort Pre-diabetics North France ( DiabeNord )</brief_title>
	<detailed_description>Type 2 diabetes ( T2D ) real public health issue , exponential incidence . Before diagnosis , several physiopathological change already take place , insulin resistance target tissue progressive inability pancreatic beta cell produce insulin . The objective study well understanding prediabetic stage mechanism involve possible development T2D , way five-year follow-up cohort study 207 prediabetic subject .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<criteria>Previous history ( within 2 month prior enrollment visit ) fast blood glucose ≥ 1,10 g/l &lt; 1,26 g/l OR fast blood glucose ≥ 1 g/l &lt; 1,10 g/l HbA1c ≥ 6,5 % . Fasting glycemia ≥ 1.26 g/l History treatment oral antidiabetic History treatment insulin , except gestational diabetes Subject history presence significant hematologic ( coagulation , thrombopenia , … ) , hepatic , renal , psychiatric disorder Subject unable follow study 5 year followup Subject exclusion period previous study simultaneously participate clinical trial metabolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pre-diabetes</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Cohort</keyword>
	<keyword>Diabetes Risk Score</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Glucose Intolerance</keyword>
	<keyword>Prediabetic State</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Endocrine System Diseases</keyword>
	<keyword>Hyperglycemia</keyword>
</DOC>